Dolly Vance | Executive Vice President, Corporate Affairs and General Counsel |
Raul Rodriguez | President and Chief Executive Officer |
Wolfgang Dummer | Executive Vice President and Chief Medical Officer |
Dave Santos | Chief Commercial Officer |
Dean Schorno | Executive Vice President and Chief Financial Officer |
Yigal Nochomovitz | Citigroup |
Nicole Gabreski | Piper Sandler |
Gary Mattan | BMO Capital Markets |
Kristen Kluska | Cantor Fitzgerald |
Joe Pantginis | H.C. Wainwright |
Greetings, and welcome to the Rigel Pharmaceuticals’ Financial Conference Call for the Second Quarter of 2021. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel.